- Home
- IMXI vs MREO Comparison
IMXI vs MREO Comparison
Compare IMXI & MREO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMXI
- MREO
- Stock Information
- Founded
- IMXI 1994
- MREO 2015
- Country
- IMXI United States
- MREO United Kingdom
- Employees
- IMXI N/A
- MREO N/A
- Industry
- IMXI Retail: Computer Software & Peripheral Equipment
- MREO Biotechnology: Pharmaceutical Preparations
- Sector
- IMXI Technology
- MREO Health Care
- Exchange
- IMXI Nasdaq
- MREO Nasdaq
- Market Cap
- IMXI 374.8M
- MREO 424.5M
- IPO Year
- IMXI N/A
- MREO N/A
- Fundamental
- Price
- IMXI $11.03
- MREO $2.15
- Analyst Decision
- IMXI Buy
- MREO Strong Buy
- Analyst Count
- IMXI 7
- MREO 7
- Target Price
- IMXI $19.60
- MREO $7.71
- AVG Volume (30 Days)
- IMXI 410.9K
- MREO 943.2K
- Earning Date
- IMXI 05-07-2025
- MREO 05-13-2025
- Dividend Yield
- IMXI N/A
- MREO N/A
- EPS Growth
- IMXI 1.60
- MREO N/A
- EPS
- IMXI 1.70
- MREO N/A
- Revenue
- IMXI $652,547,000.00
- MREO N/A
- Revenue This Year
- IMXI N/A
- MREO N/A
- Revenue Next Year
- IMXI $3.03
- MREO $54.91
- P/E Ratio
- IMXI $6.47
- MREO N/A
- Revenue Growth
- IMXI N/A
- MREO N/A
- 52 Week Low
- IMXI $10.07
- MREO $1.58
- 52 Week High
- IMXI $22.38
- MREO $5.02
- Technical
- Relative Strength Index (RSI)
- IMXI 42.91
- MREO 40.94
- Support Level
- IMXI $10.66
- MREO $2.12
- Resistance Level
- IMXI $11.73
- MREO $2.27
- Average True Range (ATR)
- IMXI 0.42
- MREO 0.13
- MACD
- IMXI 0.02
- MREO -0.02
- Stochastic Oscillator
- IMXI 33.64
- MREO 9.09
About IMXI International Money Express Inc.
International Money Express Inc is a processor of money transfer services in the USA to the Latin America and the Caribbean (LAC) corridor. The company offers wire transfer, money order, Foreign exchange, and cash checking services, while the majority of the revenue is derived from wire transfer and money order fees. The firm's business is organized around one reportable segment that provides money remittance services between the U.S. and Canada to Mexico, Guatemala, and other countries in Latin America, Africa, and Asia.
About MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).